Short answer
Oric Pharmaceuticals, Inc. (ORIC) filed an 8-K current report with the SEC on July 30, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Additional 1,100,000 shares reserved, bringing total Inducement Plan capacity to 3,350,000 shares.
Oric Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Additional 1,100,000 shares reserved, bringing total Inducement Plan capacity to 3,350,000 shares
- Equity awards issued without shareholder approval under Nasdaq inducement rules
- Awards support recruiting new employees and potentially merger or acquisition-related hires
- Potential shareholder dilution from options, restricted stock units and other equity awards
- Change-in-control provisions broadly aligned with the Company’s 2020 Equity Incentive Plan
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oric Pharmaceuticals, Inc. 8-K filings
Get the next ORIC 8-K as it lands
Follow ORIC for push alerts, or ask the research agent what this filing means.